Pharma Clear Acne Treatment

Description

No specific information related to the Description section for SPL code 34089-3 is provided in the text.

Uses and Indications

This drug is indicated for the treatment of acne and for the reduction of bacteria on the skin. There are no teratogenic effects associated with its use, nor are there any nonteratogenic effects noted.

Dosage and Administration

The product should be applied sparingly to affected blemishes following a thorough cleansing of the skin. It is essential to allow the formulation to penetrate and dry completely before the application of any other skincare preparations. For optimal results, it is recommended that the product be used twice daily.

Contraindications

The product should not be used in the following situations:

Keep out of reach of children. In the event of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately.

Avoid contact with the eyes; if contact occurs, rinse thoroughly with water.

Concurrent use with other topical acne medications may exacerbate skin dryness or irritation. If such reactions occur, only one medication should be utilized unless otherwise directed by a healthcare professional.

Limit application to the face and neck only.

Warnings and Precautions

For external use only. It is imperative that this product is kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

For external use only. No specific side effects or adverse reactions have been reported in clinical trials or postmarketing experiences.

Drug Interactions

Concurrent use of other topical acne medications with this product may lead to increased dryness or irritation of the skin. In such cases, it is advisable to limit the use to one medication at a time unless otherwise directed by a healthcare professional. Monitoring for signs of excessive dryness or irritation is recommended to ensure patient comfort and skin health.

Packaging & NDC

Below are the non-prescription pack sizes of Pharma Clear Acne Treatment (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of Pharma Clear Acne Treatment (salicylic acid concentrate) in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution when considering the use of this treatment in individuals aged 65 and older, as the absence of data necessitates careful monitoring and clinical judgment.

Pregnancy

There is currently no information available regarding the use of Pharma Clear Acne Treatment (salicylic acid concentrate) during pregnancy. This includes a lack of data on safety concerns, dosage modifications, or any special precautions that should be taken when considering treatment in pregnant patients. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this treatment to women of childbearing potential. Given the absence of specific data, it is advisable to avoid the use of this product during pregnancy unless the potential benefits outweigh the risks.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose effectively.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for appropriate treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of potential risks associated with the compound in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be cautioned to avoid contact with the eyes. If the product accidentally gets into the eyes, they should rinse thoroughly with water.

It is important to inform patients that using other topical acne medications simultaneously or immediately after applying this product may increase the risk of skin dryness or irritation. If such reactions occur, patients should be advised to use only one medication unless directed otherwise by a healthcare professional.

Additionally, healthcare providers should recommend that patients limit the use of this product to the face and neck to minimize potential adverse effects.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with a recommended frequency of twice daily for optimal results. Clinicians should advise patients to avoid contact with the eyes; in the event of contact, patients should rinse thoroughly with water. It is important to inform patients that using other topical acne medications concurrently or immediately after applying this product may lead to increased dryness or skin irritation, and only one medication should be used unless otherwise directed by a healthcare professional. Additionally, patients should limit application to the face and neck, keep the product out of reach of children, and seek medical assistance or contact a Poison Control Center if ingested.

Drug Information (PDF)

This file contains official product information for Pharma Clear Acne Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)